69 results
424B3
GOSS
Gossamer Bio Inc
28 Aug 23
Prospectus supplement
4:29pm
and the selling securityholders take no responsibility for, and can provide no assurance as to the reliability of, any other information that others may give
S-3
GOSS
Gossamer Bio Inc
18 Aug 23
Shelf registration
8:41am
by or on behalf of us or to which we have referred you. We and the selling securityholders take no responsibility for, and can provide no assurance
S-3ASR
GOSS
Gossamer Bio Inc
17 Aug 23
Automatic shelf registration
4:01pm
by or on behalf of us or to which we have referred you. We and the selling securityholders take no responsibility for, and can provide no assurance
8-K
EX-10.1
883z8xd9zld a4qtv
20 Jul 23
Gossamer Bio Announces $212 Million Private Placement Financing
4:01pm
8-K
EX-4.1
9flbn
20 Jul 23
Gossamer Bio Announces $212 Million Private Placement Financing
4:01pm
PRE 14A
qcnzth80 6r1zrime
17 Apr 23
Preliminary proxy
4:01pm
S-3ASR
i1btgjdjy1sxbhi d8h
9 Aug 22
Automatic shelf registration
12:00am
8-K
EX-10.1
n0bgt 336ccr2
13 Jul 22
Gossamer Bio Announces $120 million Private Placement Financing
8:45am
S-3ASR
7888mt y4
3 Mar 22
Automatic shelf registration
4:05pm
S-3ASR
EX-4.4
4d84fi bpx198krhd
3 Mar 22
Automatic shelf registration
4:05pm
8-K
EX-99.1
airzafnhk uj
14 Jun 21
Gossamer Bio Announces Appointment of Sandra Milligan, M.D., J.D., to its Board of Directors
4:22pm
8-K
zeooj06opkqsw3yf3gf7
14 Jun 21
Gossamer Bio Announces Appointment of Sandra Milligan, M.D., J.D., to its Board of Directors
4:22pm